New publication for the ETOP CHESS trial.
Out now in Lung Cancer Journal
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Cohort 2 with Tremelimumab in addition to Durvalumab is still recruiting.
New publication for the ETOP CHESS trial.
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Cohort 2 with Tremelimumab in addition to Durvalumab is still recruiting.